Risk factors for P. vivax recurrence between days 7 and 42 in patients treated with dihydroartemisinin-piperaquine alone.

Results of regression analyses into the associations between psychiatric symptoms and experiences of social exclusion.

Baseline demographics.

Parkinson’s disease is a neurodegenerative disorder associated with oxidative stress and the death of melanin-containing neurons of the substantia nigra. Epidemiological...

BackgroundArtemisinin-based combination therapy (ACT) is recommended for uncomplicated Plasmodium vivax malaria in areas of emerging chloroquine resistance. We undertook a...

BackgroundPrimaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate...

Multivariable model for rate of P. vivax recurrence between days 7 and 42 in patients receiving artemether-lumefantrine or dihydroartemisinin-piperaquine alone.

G6PD status classification and test performance (n = 1542).

IntroductionMigration is seen as a risk factor for developing psychiatric symptoms and experiencing social exclusion. In the Netherlands, the Moroccan-Dutch population is the...

Groups of study.

Risk factors for P. vivax recurrence between days 7 and 42 in patients treated with artemether-lumefantrine alone.